Physician profile
Tyler Wiggins
NPI 1922690304
$746.23
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $558 · 2022: $52.46 · 2023: $14.16 · 2024: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $136.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $296.45 | 2021-2024 | Andexxa |
| Dexcom, INC. | $157.62 | 2021-2023 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.20 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $43.94 | 2021 | |
| Nestle Healthcare Nutrition INC. | $42.26 | 2021-2022 | |
| Amgen INC. | $39.29 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $26.87 | 2021 | |
| Sunovion Pharmaceuticals INC. | $21.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.05 | 2021 | |
| Xeris Pharmaceuticals, INC. | $11.85 | 2021 | |
| Novo Nordisk INC | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Wiggins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.